drugset / Trial / NCT00619476
A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether gabapentin enacarbil (XP13512/GSK1838262), hereafter referred to as GEn is effective in the treatment of neuropathic pain associated with post-herpetic neuralgia (PHN).
Timeline
- Start
- 2008-02
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gabapentin enacarbil | Small molecule | 1200 mg | — |
| Subject | gabapentin enacarbil | Small molecule | 2400 mg | — |
| Subject | gabapentin enacarbil | Small molecule | 3600 mg | — |